In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months
- PMID: 29049762
- DOI: 10.7326/ACPJC-2017-167-8-043
In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months
Comment on
-
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical